Cargando…

Are all antidepressants alike?

Antidepressants are indicated in about 40 different disorders, including mood disorders, anxiety disorders, and other disorders. We propose to call these disorders antidepressani-responsive disorders (ARDs). We describe the clinical and biological criteria that differentiate the antidepressants. Alt...

Descripción completa

Detalles Bibliográficos
Autor principal: Schulz, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Les Laboratoires Servier 1999
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181566/
https://www.ncbi.nlm.nih.gov/pubmed/22033694
_version_ 1782212762409107456
author Schulz, Pierre
author_facet Schulz, Pierre
author_sort Schulz, Pierre
collection PubMed
description Antidepressants are indicated in about 40 different disorders, including mood disorders, anxiety disorders, and other disorders. We propose to call these disorders antidepressani-responsive disorders (ARDs). We describe the clinical and biological criteria that differentiate the antidepressants. Although antidepressants share the same clinical efficacy in most ARDs, the configuration of adverse drug reactions varies widely. The recent antidepressants should be preferred to the tricyclic antidepressants as first-line treatment because of their lesser risk of severe adverse drug reactions. However, several recent antidepressants have been associated with severe complications such as the serotonin syndrome and the withdrawal syndrome. Patient characteristics should be included as a criterion to predict both unwanted and favorable effects.
format Online
Article
Text
id pubmed-3181566
institution National Center for Biotechnology Information
language English
publishDate 1999
publisher Les Laboratoires Servier
record_format MEDLINE/PubMed
spelling pubmed-31815662011-10-27 Are all antidepressants alike? Schulz, Pierre Dialogues Clin Neurosci Pharmacological Aspects Antidepressants are indicated in about 40 different disorders, including mood disorders, anxiety disorders, and other disorders. We propose to call these disorders antidepressani-responsive disorders (ARDs). We describe the clinical and biological criteria that differentiate the antidepressants. Although antidepressants share the same clinical efficacy in most ARDs, the configuration of adverse drug reactions varies widely. The recent antidepressants should be preferred to the tricyclic antidepressants as first-line treatment because of their lesser risk of severe adverse drug reactions. However, several recent antidepressants have been associated with severe complications such as the serotonin syndrome and the withdrawal syndrome. Patient characteristics should be included as a criterion to predict both unwanted and favorable effects. Les Laboratoires Servier 1999-06 /pmc/articles/PMC3181566/ /pubmed/22033694 Text en http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pharmacological Aspects
Schulz, Pierre
Are all antidepressants alike?
title Are all antidepressants alike?
title_full Are all antidepressants alike?
title_fullStr Are all antidepressants alike?
title_full_unstemmed Are all antidepressants alike?
title_short Are all antidepressants alike?
title_sort are all antidepressants alike?
topic Pharmacological Aspects
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181566/
https://www.ncbi.nlm.nih.gov/pubmed/22033694
work_keys_str_mv AT schulzpierre areallantidepressantsalike